Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Company Overview - Alexandria Real Estate is a real estate investment trust (REIT) focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Financial Performance - Alexandria Real Estate reported disappointing results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on consecutive days [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property, which was deemed not suitable for life science scaling [5][6]. Legal Proceedings - Investors have until January 26, 2026, to request to lead the class action case, which is pending in the U.S. District Court for the Central District of California [3]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Alexandria Real Estate securities [3].

Core Viewpoint - A class action lawsuit has been filed against Fermi Inc. for allegedly making materially false and misleading statements regarding its business operations and prospects during its IPO and subsequent trading period [1][6]. Group 1: Lawsuit Details - The lawsuit is filed in the United States District Court for the Southern District of New York, under the case name Lupia v. Fermi, Inc., and is on behalf of individuals and entities that purchased Fermi's common stock during the IPO and the class period from October 1, 2025, to December 11, 2025 [1]. - The lawsuit claims violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1]. Group 2: IPO and Stock Performance - Fermi conducted its IPO on October 1, 2025, selling 37,375,000 shares at a price of $21.00 per share [3]. - Following the announcement of a significant tenant's termination of a $150 million funding agreement, Fermi's stock price dropped by $5.16, or 33.8%, closing at $10.09 on December 12, 2025 [4]. - By the time the lawsuit commenced, Fermi's stock had fallen to as low as $8.59 per share, representing a 59% decline from the IPO price [5]. Group 3: Allegations Against Defendants - The complaint alleges that Fermi's Registration Statement and statements made during the class period contained materially false and misleading information, including an overstatement of tenant demand for the Project Matador campus and reliance on a single tenant's funding commitment [6]. - It is claimed that the defendants failed to disclose the significant risk of the tenant terminating its funding commitment, which misled investors regarding the company's business and operational prospects [6].

PHILADELPHIA, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating PrimeEnergy Resources Corporation (NASDAQ: PNRG) (“PrimeEnergy”) on behalf of the company’s shareholders to determine whether PrimeEnergy and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions.  Since March 2025, shares of PrimeEnergy’s common stock have declined in value from a trading price of over $228.00 per sh ...

NEW YORK, Jan. 5, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds persons who invested in securities of SLM Corporation a/k/a Sallie Mae (NASDAQ: SLM) between July 25, 2025 and August 14, 2025, both dates inclusive (the "Class Period"), of the important February 17, 2026 lead plaintiff deadline. So what: If you purchased SLM securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ...

Philadelphia, Pennsylvania--(Newsfile Corp. - January 5, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) ("Integer" or the "Company") on behalf of investors who purchased or otherwise acquired Integer securities during the period of July 25, 2024 through October 22, 2025 (the "Class Period"), inclusive.Investor Deadline: Investors who purchased Integer securities during the Class Period may, no l ...

San Diego, California--(Newsfile Corp. - January 5, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of StubHub Holdings, Inc. (NYSE: STUB) common stock pursuant and/or traceable to StubHub's offering documents issued in connection with StubHub's September 17, 2025 initial public offering ("IPO"), have until Friday, January 23, 2026 to seek appointment as lead plaintiff of the StubHub class action lawsuit. Captioned Salabaj v. StubHub Holdings, Inc., No. 25-cv-09776 (S.D.N.Y. ...

SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that investors in SLM Corporation a/k/a Sallie Mae (NASDAQ: SLM; SLMBP) securities between July 25, 2025 and August 14, 2025, both dates inclusive (the "Class Period†), have until February 17, 2026 to seek appointment as lead plaintiff of the SLM class action lawsuit. Captioned Zappia v. SLM Corporation a/k/a Sallie Mae, No. 25-cv-18834 (D.N.J.), the SLM class action lawsuit charges SLM as well as certain of SLM's top e ...

SAN FRANCISCO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is alerting investors in Primo Brands Corporation (NYSE: PRMB) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 12, 2026.   The firm urges investors who suffered substantial losses to contact our firm now. The lawsuit seeks to recover investor losses sustained after the disclosure of an allegedly concealed severe, operational crisi ...

Philadelphia, Pennsylvania--(Newsfile Corp. - January 5, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) ("Stride" or the "Company") on behalf of investors who purchased Stride securities during the period of October 22, 2024 through October 28, 2025 (the "Class Period").Investor Deadline: Investors who purchased Stride securities during the Class Period may, no later than January 12, 2026, seek to be appointed a ...

PHILADELPHIA, Jan. 5, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceuticals Ltd. (NASDAQ: TLX) ("Telix" or the "Company") on behalf of investors who purchased Telix securities during the period of February 21, 2025 through August 28, 2025 (the "Class Period"). Investor Deadline: Investors who purchased Telix securities during the Class Period may, no later than January 9, 2026, seek to be appointed as a lead ...